KalVista Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KALV and other ETFs, options, and stocks.About KALV
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa.
CEOBenjamin L. Palleiko
CEOBenjamin L. Palleiko
Employees270
Employees270
HeadquartersFramingham, Massachusetts
HeadquartersFramingham, Massachusetts
Founded2004
Founded2004
Employees270
Employees270
KALV Key Statistics
Market cap702.85M
Market cap702.85M
Price-Earnings ratio-3.48
Price-Earnings ratio-3.48
Dividend yield—
Dividend yield—
Average volume1.39M
Average volume1.39M
High today$14.36
High today$14.36
Low today$13.45
Low today$13.45
Open price$14.15
Open price$14.15
Volume733.45K
Volume733.45K
52 Week high$17.28
52 Week high$17.28
52 Week low$7.30
52 Week low$7.30
Stock Snapshot
As of today, KalVista Pharmaceuticals(KALV) shares are valued at $13.92. The company's market cap stands at 702.85M, with a P/E ratio of -3.48.
On 2025-12-01, KalVista Pharmaceuticals(KALV) stock traded between a low of $13.45 and a high of $14.36. Shares are currently priced at $13.92, which is +3.5% above the low and -3.1% below the high.
The KalVista Pharmaceuticals(KALV)'s current trading volume is 733.45K, compared to an average daily volume of 1.39M.
In the last year, KalVista Pharmaceuticals(KALV) shares hit a 52-week high of $17.28 and a 52-week low of $7.30.
In the last year, KalVista Pharmaceuticals(KALV) shares hit a 52-week high of $17.28 and a 52-week low of $7.30.
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own KALV. This list is generated using Robinhood data, and it’s not a recommendation.